Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Newsenselab logo — Newsenselab GmbH created M-sense, the first prescription mig...

Newsenselab

Newsenselab GmbH created M-sense, the first prescription migraine app to help sufferers reduce headaches.

Founded 2016 Germany Berlin, Germany 2-10 employees Seed Total: $1.58M Digital Health, Health Care +1

General Information

Company Name Newsenselab
Founded Year 2016
Location Germany Berlin, Germany
Founders / Decision Makers
Team member
Employees 2-10
Industries Digital Health, Health Care, Health and Wellness
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with Newsenselab. To contact Newsenselab, visit m-sense.de.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Newsenselab compare?

A PDF of Newsenselab and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Newsenselab soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Newsenselab

Newsenselab GmbH, founded in 2016, is an innovator in the Digital Health industry, headquartered in Germany. The company developed M-sense, the first prescription migraine app, transforming migraine management for patients. This cutting-edge digital therapeutic is crafted alongside leading headache specialists, aiming to significantly alleviate sufferers’ headaches.

The company captured attention within the healthcare sector, culminating in a €375.00K Seed Round investment, finalized on 20 December 2021. This funding round was backed by notable investors including IBB Ventures, Noaber, HTGF | High-Tech Gründerfonds, and MedTech Entrepreneurs (MTE).

The visionary approach of Newsenselab places it at the forefront of digital health innovation. With its pioneering digital solutions, the company is strategically positioned to capitalize on growing trends in health tech, offering significant potential for future investors.

Business keywords: digital therapeutic, migraine app, prescription app, medical app, headache management, health technology, personalized therapy, headache specialists, digital health

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round Newsenselab (M €375.00K 4
IBB Ventures
IBB Ventures, Noaber +2
20 Dec 2021
Seed Round Newsenselab (M €1.20M 4
IBB Ventures
IBB Ventures, HTGF | High-Tech Gruenderfonds +2
03 Dec 2019
Venture Round Newsenselab (M Undisclosed 2
Think.Health, HTGF | High-Tech Gruenderfonds
24 Jan 2018
Venture Round Newsenselab (M Undisclosed -
28 Nov 2016

Newsenselab Alternatives & Competitors

View All Alternatives
Newsenselab vs
Facial Pain Specialists
Facial Pain Specialists United States

Face Pain • TMJ • Headache

10 employees
Health Care, Health and Wellness
Newsenselab vs
Skin + Me
Skin + Me United Kingdom

We’re on a mission to build an accessible way for people to achieve their skin goals with powerful p...

Series B
215 employees
Health Care, Health and Wellness
Newsenselab vs
Selfapy
Selfapy Germany

Selfapy macht psychologische Unterstützung für jede*n möglich.

Venture round
30 employees
Health Care, Health and Wellness
View all alternatives

FAQ About Newsenselab

Newsenselab GmbH created M-sense, the first prescription migraine app to help sufferers reduce headaches.
Newsenselab was founded in 2016.
Newsenselab is headquartered in Berlin, Germany.
Newsenselab operates in Digital Health, Health Care and Health and Wellness. Its work centres on digital therapeutic, migraine app, prescription app and medical app.
Newsenselab has approximately 2-10 employees.
Newsenselab has completed 4 funding rounds, raising a total of $1.58M. The latest funding stage is Seed.
Top alternatives and competitors to Newsenselab include Facial Pain Specialists, Skin + Me, Selfapy, minime.health, Joint Academy. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Newsenselab and Facial Pain Specialists are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Newsenselab, https://bouncewatch.com/company/newsenselab, updated 6 September 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes